SCHEMBL24309807

SCHEMBL24309807

CC(C)OCc1ccccc1-c1cc(Oc2ccc(N3CCN(C)CC3)cc2)nc(NSc2cnn(C)c2)n1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 2/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ GSK3B P49841 2/20 0.33
▸ MAP4K1 Q92918 2/20 0.32
▸ ITK Q08881 1/20 0.32
▸ BRD4 O60885 2/20 0.32
▸ FGFR1 P11362 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ALK Q9UM73 1/20 0.30
▸ PDE2A O00408 1/20 0.30
▸ PDE10A Q9Y233 1/20 0.30
▸ KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310306 0.90 CDK4 (0.34) CDK4CDK2GSK3BMAP4K1ITK
SCHEMBL24310517 0.88 CDK4 (0.33) CDK4CDK2GSK3BMAP4K1BRD4
SCHEMBL24310329 0.88 MET (0.32) CDK4CDK2GSK3BMAP4K1
SCHEMBL29567566 0.85 HTR2C (0.36) CDK4CDK2GSK3BBRD4NPC1
SCHEMBL24309804 0.85 HTR2C (0.36) CDK4CDK2GSK3BBRD4NPC1
SCHEMBL24310522 0.85 MAP4K1 (0.31) CDK4CDK2GSK3BMAP4K1BRD4
SCHEMBL24310325 0.84 MAP4K1 (0.32) CDK4CDK2GSK3BMAP4K1FGFR1
SCHEMBL24310318 0.83 MAP4K1 (0.42) MAP4K1NPC1MAPTMAPK1RAB9A
SCHEMBL24310560 0.80 IRAK4 (0.34) CDK4MAP4K1BRD4NPC1TP53
SCHEMBL24309676 0.78 FLT3 (0.38) CDK4CDK2MAP4K1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback